Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.39 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.38 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.36 |
| ▸ | CDC25A | P30304 | 2/20 | 0.36 |
| ▸ | OSBP | P22059 | 1/20 | 0.36 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10016109 | 0.92 | CYP2D6 (0.39) | CYP2D6CYP2C19INPP5DSRD5A1SRD5A2 | |
| SCHEMBL257593 | 0.92 | CYP2D6 (0.48) | CYP2D6CYP2C19INPP5DSRD5A1SRD5A2 | |
| SCHEMBL11994877 | 0.88 | RORC (0.42) | CYP2D6CYP2C19INPP5DGRIN1GRIN2A | |
| SCHEMBL257586 | 0.87 | GPBAR1 (0.38) | CYP2D6CYP2C19INPP5D | |
| SCHEMBL9999572 | 0.86 | CYP2D6 (0.48) | CYP2D6CYP2C19INPP5DSRD5A1SRD5A2 | |
| SCHEMBL10015980 | 0.86 | RORC (0.47) | — | |
| SCHEMBL15043341 | 0.84 | PTPN1 (0.40) | SRD5A2 | |
| SCHEMBL12075326 | 0.81 | GRIN1 (0.37) | SRD5A1GRIN1GRIN2B | |
| SCHEMBL16982190 | 0.81 | CYP2D6 (0.46) | CYP2D6CYP2C19INPP5DSRD5A1SRD5A2 | |
| SCHEMBL9999583 | 0.80 | RORC (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018043325-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | 日産化学工業株式会社 | 2018-03-08 | — | — | WO | disclosed |
| WO-2018043326-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 | 2018-03-08 | — | — | WO | disclosed |
| US-9447240-B2 | Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using it | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| US-9447240-B2 | Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using it | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20140066590-A1 | POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-06 | — | — | US | disclosed |
| WO-2013094618-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY ELEMENT USING SAME, AND COMPOUND | 日産化学工業株式会社 (JP) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013081064-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | 日産化学工業株式会社 (JP) | 2013-06-06 | — | — | WO | disclosed |
| WO-2012161329-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | 日産化学工業株式会社 (JP) | 2012-11-29 | — | — | WO | disclosed |
| WO-2012029763-A1 | DIAMINE, POLYIMIDE PRECURSOR, POLYIMIDE, LIQUID-CRYSTAL ALIGNMENT MATERIAL, LIQUID-CRYSTAL ALIGNMENT FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 (JP) | 2012-03-08 | — | — | WO | disclosed |
| WO-2011136371-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 (JP) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140066590-A1 | POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT | CCDC22, RCC1, MACF1 | CYP2D6 4364/4885CYP2C19 2862/4885INPP5D 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.